Vogelstein's group presented a surprising finding that genetic inactivation of both Akt1 and Akt2 resulted in a striking decrease in liver metastasis in a colon cancer mouse model, which correlated with the activation of FOXO proteins, but not the well-known downstream signaling target GSK3b nor mTOR [21]. The gene discussed is AKT1; the disease is colonic neoplasm.